Search company, investor...

Adeona Pharmaceuticals

adeonapharma.com

Founded Year

2001

Stage

Unattributed VC | Alive

Total Raised

$9.2M

Last Raised

$9.2M | 16 yrs ago

About Adeona Pharmaceuticals

Adeona Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Ann Arbor, Michigan. Adeona Pharmaceuticals' investors include Firebird Capital, SDS Capital Partners, Chestnut Ridge Partners, Gemini Investment Strategies, Iroquois Capital, Perceptive Advisors, AFA Private Equity Fund, William Harris Investors, Whalehaven Capital and Ridgeback Capital.

Headquarters Location

3930 Varsity Drive

Ann Arbor, Michigan, 48108,

United States

734-332-7800

Missing: Adeona Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Adeona Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Adeona Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Adeona Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Adeona Pharmaceuticals News

Synthetic Biologics Inc SYN Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250

Sep 17, 2017

Summary Synthetic Biologics Inc Synthetic Biologics, formerly Adeona Pharmaceuticals Inc is a clinical company that concentrates on the development of novel therapeutics to treat gut microbiome. The company's pipeline products include ribaxamase and SYN010. Its SYN010 is a drug candidate which is intended to treat rritable bowel syndrome with constipation . Synthetic Biologics develops preclinical monoclonal antibody therapies for the treatment of pertussis, and novel discovery stage biotherapeutics for the treatment of phenylketonuria. The company undertakes several research activities to develop therapeutics. It collaborates with various academic and pharmaceutical companies to develop its product candidates. Synthetic Biologics is headquartered in Rockville, Maryland, the US. Synthetic Biologics Inc SYN Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Adeona Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Adeona Pharmaceuticals founded?

    Adeona Pharmaceuticals was founded in 2001.

  • Where is Adeona Pharmaceuticals's headquarters?

    Adeona Pharmaceuticals's headquarters is located at 3930 Varsity Drive, Ann Arbor.

  • What is Adeona Pharmaceuticals's latest funding round?

    Adeona Pharmaceuticals's latest funding round is Unattributed VC.

  • How much did Adeona Pharmaceuticals raise?

    Adeona Pharmaceuticals raised a total of $9.2M.

  • Who are the investors of Adeona Pharmaceuticals?

    Investors of Adeona Pharmaceuticals include AFA Private Equity Fund, Firebird Capital, Chestnut Ridge Capital, Perceptive Advisors, Gemini Investment Strategies and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.